AliveCor Announces Strategic Additions to Executive Team
Retrieved on:
Tuesday, January 11, 2022
Cloud, Patient, Technology, HPE, Stroke, Amazon, Cardiac cycle, Arrhythmia, Adoption, IBM, Amwell, Corona Regional Medical Center, ECG, Sequoia, CEO, Reckitt, Initial public offering, Salesforce, Leadership, Atrial fibrillation, Stanford University, Health, Deep learning, Cisco Systems, GSK, Global Medical Device Nomenclature, Therapy, Multimedia, HIPAA, Bálsamo, Abani, Marketing, HP, Sale, FDA, Ectopia, Compliance, Principal, Senior, Google, Management, Pharmaceutical industry, Medical device, Alivecor, ResMed, Tachycardia, Bradycardia, Medicine
Balsamo joins AliveCor from a Sequoia-backed stealth AI company, where he served as Chief Revenue Officer and interim Co-CEO.
Key Points:
- Balsamo joins AliveCor from a Sequoia-backed stealth AI company, where he served as Chief Revenue Officer and interim Co-CEO.
- In that role, he oversaw commercial operations, managed strategic partnerships, helped close a $25 million strategic funding round, and oversaw a corporate restructuring.
- Dr. Archana Dubey brings more than 25 years of experience as a physician, executive, entrepreneur, and strategic advisor to her role at AliveCor.
- AliveCor is a privately-held company headquartered in Mountain View, Calif. "Consumer" or "Personal" ECGs are ECG devices available for direct sale to consumers.